Springbok Capital Management »

Cytomx Therapeutics shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $659k 207k 3.19
2020-09-30 $11k 1.7k 6.47
2020-06-30 $3.0k 400 7.50
2019-06-30 $7.0k 611 11.46
2018-09-30 $1.0k 72 13.89
2018-06-30 $239k 11k 22.86
2018-03-31 $34k 1.2k 28.26
2017-12-31 $8.0k 401 19.95
2017-06-30 $5.0k 300 16.67